Moreover, VPS35 overexpression dramatically increased neuronal vulnerability to PD-relevant cellular stressors, including the mitochondrial Complex-I inhibitors MPP+ and rotenone, rather than eliciting neuroprotection as previously suggested (26). Here, VPS35 is linked to Parkinson disease.